Dynavax Technologies (DVAX) halted ahead of FDA adcom
- Pfizer, Inc. (PFE) Tops Q2 EPS by 1c
- Pre-Open Stock Movers 7/29: (GEVO) (FTR) (WIN) (PLUG) Higher; (KBIO) (HLF) (LOCO) (UPS) Lower (more...)
- Windstream (WIN) Plans to Spin Certain Telecom Assets Into Public REIT
- Merck & Co., Inc. (MRK) Tops Q2 EPS by 5c
- UPS (UPS) Misses Q2 EPS by 4c; Cuts FY14 EPS Outlook
Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom
You May Also Be Interested In
- UPDATE: Impax Laboratories (IPXL) Issued Form 483 Following FDA Inspection of Taiwan Facility
- Apple (AAPL) Nears $100 ($700 Pre-Split)
- BlackBerry (BBRY) Sees Upside Following Blog Post
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!